<i>MTARC1</i> and <i>HSD17B13</i> Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery

<i>MTARC1</i> and <i>HSD17B13</i> Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery

The severity of hepatic steatosis is modulated by genetic variants, such as patatin-like phospholipase domain containing 3 (<i>PNPLA3</i>) rs738409, transmembrane 6 superfamily member 2 (<i>TM6SF2</i>) rs58542926, and membrane-bound O-acyltransferase domain containing 7 (<...

Full description

Bibliographic Details
Main Authors: Piotr Kalinowski, Wiktor Smyk, Małgorzata Nowosad, Rafał Paluszkiewicz, Łukasz Michałowski, Bogna Ziarkiewicz-Wróblewska, Susanne N. Weber, Piotr Milkiewicz, Frank Lammert, Krzysztof Zieniewicz, Marcin Krawczyk
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
liver fibrosis
mitochondrial amidoxime-reducing component 1
NAFLD
NASH
weight-loss surgery
Online Access:https://www.mdpi.com/1422-0067/23/24/15825

Internet

https://www.mdpi.com/1422-0067/23/24/15825

Similar Items